FOOD AND DRUG ADMINISTRATION

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

 

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE

 

MEETING ON INFLUENZA VIRUS VACCINE FORMULATION FOR 2003-2004

 

 

MEETING BY TELECONFERENCE

AGENDA

Tuesday, March 18, 2003

 

Food and Drug Administration

5515 Security Lane

Conference Room A on the 11th Floor

Suite 1113, Rockville, MD

10:30 AM EST

            Draft Agenda

 

                       10:30 AM            Call to Order                                                             Dr. David Stephens, Committee Chair

 

                       10:35                        Announcements                                                 Dr. Jody Sachs, FDA

 

                        10:40                Open Session

                                                Strain Selection for the Influenza Virus Vaccine for 2003-2004

                                               

                                                Introduction and Review                                     Dr. Levandowski, FDA

                                                Additional Information, H3N2                            Dr. Nancy Cox, CDC

                                                                                                                       

                                                                                                                       

                        11:10            Committee Discussion                                                 Dr. Levandowski, FDA

                                                            

                        11:30            Open Public Hearing

 

                        12:30                Recommendations for Influenza Virus Vaccine for 2003-2004

                       

                        12:45                Adjournment